MeiraGTx Holdings plc (MGTX) Reports Publication of Phase 2 Study Results on Mechanism of Functional Improvement Seen with AAV-GAD Gene Therapy in Parkinson’s Disease
Tweet Send to a Friend
MeiraGTx Holdings plc (NASDAQ: MGTX) today announced publication of research assessing the mechanism underlying the motor improvement observed in patients ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
